Startup and Venture Investment News for July 24, 2026: Record $510 Billion in Half-Year, Capital Concentration in AI, Major Rounds, IPOs, and M&A — Overview for Investors
The global venture market enters the end of July 2026 in a state that is difficult to describe with a single term. Formally, this is the best half-year in the history of the industry: global venture investments reached a record $510 billion in the first half of 2026, surpassing the total for all of 2025 ($440 billion). However, behind the record figures lies an unprecedented concentration: two companies — OpenAI and Anthropic — attracted $217 billion, or 43% of all venture dollars worldwide. For venture investors and funds, this signifies not a "boom" but a restructuring of the very logic of capital distribution.
The key thesis from the recent trading sessions and funding rounds is this: investors are no longer paying for "exposure to AI" as such. They are paying for control over bottlenecks — for infrastructure, regulated workflows, manufacturing capacities, and systems that cannot be replaced by a single API call. Deals announced this week demonstrate this logic with rare clarity.
Record Half-Year and the Price of Capital Concentration
The statistics for the first half of 2026 have rewritten all historical benchmarks of the venture market:
- $510 billion — global venture investments for H1 2026, compared to $375 billion in the peak half-year of 2021.
- $305 billion — first quarter, the largest quarter in the industry's history.
- $205 billion — second quarter, distributed among more than 5,000 startups.
- Over 70% of the capital in Q2 went to AI-focused companies — up from less than 50% a year earlier.
- 53% of Q2's volume came from mega-rounds of $1 billion or more: 16 companies raised $108.6 billion.
For venture funds, this creates uncomfortable arithmetic. A manager without allocation in OpenAI or Anthropic effectively posted weak half-year results — not because of poor portfolio selection, but because the market benchmark was established by two capital tables. Late-stage funding grew by 141% year-on-year in Q2: capital did not widen its reach but deepened positions in already proven winners.
Exits Have Returned: Record Quarter for IPOs and M&A
The most important news for LPs is not the volume of investments but the restoration of liquidity. It is exits, not paper markups, that pay for the returns of fund vintages.
- 32 companies went public with valuations above $1 billion in Q2 2026.
- SpaceX's IPO on June 12 became the largest venture company's offering in history: $75 billion raised at a valuation of $1.77 trillion, with shares closing up 19%.
- 24 companies were acquired for prices starting at $1 billion, with a total volume of $113 billion, a record in history.
- Acquisition of Anysphere (Cursor) by SpaceX for $60 billion — the largest startup acquisition in market history.
- The next largest offerings after SpaceX were made by inference chip manufacturer Cerebras Systems and quantum company Quantinuum.
The long-standing bottleneck in the exit queue has finally begun to dissolve. For late investors, this fundamentally changes the risk calculation: private capital is again converting into real liquidity rather than just headline valuations.
Cybersecurity: The Category with the Highest Conversion Conviction
Cybersecurity continues to be a field where venture funds are willing to commit at scale before revenue is disclosed. The company Glow emerged from stealth mode with a Series A round of $180 million at a valuation of $1.2 billion. The syndicate included Sequoia Capital, Cyberstarts, Greenoaks, Redpoint Ventures, Index Ventures, Lux Capital, and Operator Collective.
Glow’s thesis is straightforward and thus compelling: the endpoint is becoming the primary attack surface in an era where employees launch AI agents, install developer tools in minutes, and introduce risk faster than security can respond. The company aims not to serve as yet another detection layer alongside CrowdStrike, Microsoft, SentinelOne, and Palo Alto Networks but to position itself at the political and orchestration level, determining which software and agents are allowed to enter the perimeter.
In the same segment, StrongestLayer raised $4.1 million led by Inovia Capital, bringing its seed funding total to $9.3 million. The company builds email protection based on reasoning about message intent rather than signatures and reputation databases — a response to the rise of BEC-type attacks that do not contain overtly malicious payloads.
Defense Technologies: Geopolitics as an Investment Thesis
The most politically charged deal of the week was the round for Cathedral: $160 million at a valuation of $1.4 billion, co-led by Andreessen Horowitz and Sequoia Capital. The startup, founded by alumni from the Department of Government Efficiency, is developing AI systems for military cyber operations — both defensive and offensive — and is reportedly exploring acquisition or partnership opportunities for dedicated computing power.
For venture investors, Cathedral illustrates three converging forces: AI-based national security software, direct connections between founders and federal procurement circles, and the conviction of capital that geopolitical competition justifies aggressive underwriting. The downside is political risk: proximity to power accelerates contracts but makes the company vulnerable in the event of a political shift.
Physical AI and Robotics: From Demos to Unit-Economics
Robotics attracted $18.8 billion since the beginning of 2026 — already more than in all of 2025. A key change is the nature of argumentation from founders: buyers are no longer interested in demonstrations but in throughput, uptime, and cost.
- Humanoid (London) — $152 million Series A at a post-money valuation of $1.35 billion, led by Prime Movers Lab with participation from Schaeffler, Bosch, Fubon Financial Holding Venture Capital, and Aglaé Ventures. Total capital raised amounts to $270 million. Partnerships with SAP, NVIDIA, Bosch, and Siemens and a commercial agreement with Schaeffler transition the project from prototypes to industrial deployment. The company positions the round as proof of Europe's capability to grow globally competitive players in physical AI.
- Gritt — $26 million Series A led by Obvious Ventures, with participation from Union Square Ventures and Active Impact Investment. The company automates solar power plant installations: a crew of eight installs about 800 panels a day using traditional methods compared to 3,000–4,000 with Gritt’s systems. Contracted volume — 2.8 GW over the next 18 months.
- 1872 (Cincinnati) — $15 million seed round from The O.H.I.O. Fund. The founders are former SpaceX engineers building an autonomous metal structure factory in partnership with Path Robotics.
Energy and Materials: Sovereignty of Supply Chains as an Asset Class
The company Sila raised $300 million led by Atreides Management and Sutter Hill Ventures with participation from 8VC, Bessemer Venture Partners, Matrix Partners, and funds managed by T. Rowe Price. Total funding has reached approximately $1.6 billion. The funds will be used to expand the production of silicon-carbon anodes in Moses Lake, Washington.
The investment thesis here is broader than the electric vehicle market: Sila sells technology to drones, satellites, electronics, robotics, and AI systems simultaneously. Capital is seeking "shovels and pickaxes" capable of riding multiple demand curves — especially where data centers and defense procurement are driving upward demand for batteries.
A separate mention is warranted for Bluecore Energy — a pre-seed round of ~$10 million led by Slauson & Co. The company is developing small modular reactors with water cooling on floating barges and has already delivered the first barge with a test reactor to Long Beach port. The initial 10 MW system is designed to power the equivalent of 15,000 households or a large port. The AI appetite for electricity has become a self-sustaining driver for startup formation.
Fintech: Fewer Deals, More Infrastructure
Global fintech funding grew by approximately 23% year-on-year in the first half of 2026, despite a drop in the number of deals by more than 25%. Capital is focusing on large infrastructure bets.
- Augustus — $180 million Series B at a valuation of $1 billion, led by Tiger Global with participation from Hummingbird and QED. The company is building a "Global Dollar Bank" — direct access for international fintechs and banks to dollar accounts and clearing rails through a federally chartered institution with conditional approval from OCC. Total capital raised amounts to $210 million.
- Cashea (Caracas) — $100 million, disclosed in one announcement: Series A of $40 million led by Spice Expeditions (March 2026) and Series B of $60 million led by FinSight Ventures (June 2026). Over 10 million consumer accounts, 40,000 stores, and more than 100 million transactions. The case demonstrates that frontier geographies can secure funding if the company shows density of local distribution and payment discipline among borrowers.
Healthcare and Biotech: Capital Has Become Disciplined
Biotech financing has split into two distinct segments. Late-stage, clinically de-risked assets still attract over-subscribed rounds; early projects are funded only under narrow, specific technical wedges.
- Crystalys Therapeutics — $130 million Series B led by Frazier Life Sciences, with participation from Wellington Management, HBM Healthcare Investments, Soleus Capital, Cormorant Asset Management, Novo Holdings, and SR One. Total funding is $335 million. The funds are directed towards Phase 3 and preparations for the commercialization of the drug dotinurad against gout.
- Candid Health — $120 million Series D led by Sixth Street Growth, with participation from Oak HC/FT, 8VC, and Y Combinator. The company automates the cycle of medical billing — a segment that burns about $280 billion annually in the U.S. healthcare system. Valuation has tripled since Series C, with contracted annual revenue growth at 190% year-on-year and net dollar retention at 180%.
- Tikva Allocell (Singapore) — $8 million Series A from Kantharos Capital to submit an IND application by the end of the year.
- Brenus Pharma (Lyon) — €11 million Series A extension, totaling €38 million, with participation from Bpifrance, Sambrinvest, and Korea Omega Investment Corp.
- Immitra Bio (Zurich) — €2.58 million pre-seed led by Backbone Ventures and OCCIDENT for developing in-vivo genome editing.
Second-Order AI Infrastructure: Orchestration Over Models
A distinct emerging class of deals involves companies making already-built AI infrastructure feasible for industrial use. Meshy raised nearly $400 million in Series B at a valuation of $1.5 billion — the largest disclosed round in the AI-3D segment; the company's products are utilized by teams within five of the ten largest tech corporations globally, with ARR increasing approximately 12-fold year-on-year. SkyPilot emerged from stealth mode with $20 million in seed funding led by Lux Capital, with participation from Amplify Partners, Coatue, and Foundation Capital: the company combines fragmented computing resources — hyperscalers, neo-clouds, Kubernetes clusters, and various types of accelerators — into a single management layer.
The British company CuspAI previously this week closed Series B at $450 million with backing from Kleiner Perkins, NEA, Bezos Expeditions, the UK government, AMD Ventures, and Lux Capital, bringing the total raised to over $650 million. The focus is on AI for discovering new materials.
What This Means for Venture Funds and Institutional Investors
Practical takeaways for capital managers at the end of July 2026:
- Record volumes do not equate to a broad market. With $510 billion in the half-year, 43% went to two companies. When assessing portfolio returns, it is more accurate to use median rather than weighted average benchmarks.
- The quality of the syndicate has become a signal of survival. The market rewards the presence of specialized lead investors capable of supporting a company in subsequent rounds — this influences the price as much as metrics do.
- Security is determined by control, not technology. Manufacturing assets, regulatory licenses, built-in distribution, workflow data — these are what survive the commoditization of models.
- The exit window is open, but selectively. Record IPOs and M&A in Q2 provide late investors reasons to exit, but the public market accepts companies that resemble infrastructure rather than just a feature.
- Geography has yielded to categories. The share of the U.S. decreased from 83% in Q1 to two-thirds in Q2 — an early signal of capital redistribution towards Europe and Asia.
- Capital efficiency has returned to the agenda. Companies demonstrating growth with a small team and positive unit economics receive premium valuations that were absent in the "growth at any cost" cycle.
Conclusion: The Market is Narrow, but Open
The venture market at the end of July 2026 is neither overheated nor closed. It is narrow, strategic, and increasingly intolerant of abstractions. Large checks continue to be written — but are more frequently reserved for companies that do not appear as experiments but as future infrastructure of specific segments of the economy. For venture investors and funds, the key skill in the new cycle will be the ability to distinguish between a company that controls a bottleneck and a company selling a function atop someone else's model. This distinction, rather than the pace of growth in the AI industry, will determine the returns of the 2026 vintages.
